ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 846

Progression of Left Ventricular Myocardial Dysfunction in Systemic Sclerosis: Using Speckle Tracking Strain Echocardiography to Identify Patients at Risk

Susanne Van Wijngaarden1, Samira Ben Said- Bouyeri2, Maarten K. Ninaber3, J.J. Bax1, V. Delgado1, Jeska K. de Vries-Bouwstra4 and Nina Ajmone Marsan1, 1Heart and Lung Center, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Heart and Lung Center; Pulmonology, Leiden University Medical Center, Leiden, Netherlands, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: imaging techniques, myocardial involvement and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Cardiac involvement is a main cause of mortality in systemic sclerosis, although reported prevalence of cardiac involvement is low and detection of cardiac involvement remains challenging. Speckle-tracking strain analysis of echocardiographic images can detect subtle myocardial dysfunction in systemic sclerosis patients. Objectives: This study evaluated: 1. changes in cardiac performance over time including echocardiographic myocardial speckle tracking strain analysis in a large cohort of systemic sclerosis patients, not selected for disease severity,  and 2. baseline characteristics associated with deterioration of cardiac function.

Methods: 235 systemic sclerosis patients (197 female, 52±14 years), all fulfilling ACR 2013 or Leroy 2001 criteria for systemic sclerosis, were evaluated at baseline and follow-up (2.3 years, interquartile range 1.3-3.8), including complete physical examination and screening for organ involvement with at least high resolution computed tomography of the thorax, pulmonary function test, cardiopulmonary exercise test, electrocardiography and echocardiography.

Results: Left ventricular ejection fraction did not change significantly (62%±7 vs 61%±8,p=0.148) while global longitudinal strain decreased significantly (-21%±2 vs -19%±2, p<0.001). 39 patients showed progression of left ventricular dysfunction as defined by ≥15% decline in longitudinal strain. These patients showed significant worsening of left ventricular diastolic function and Tricuspid Annular Plane Systolic Excursion (TAPSE ; 22mm±4 versus 19mm±4, p=0.003) and 6% developed pulmonary hypertension. Multivariate analysis showed that at baseline proximal muscle weakness (Odds Ratio: 3.7; interquartile range:1.3–10.4), diffusing capacity of carbon monoxide (Odds Ratio: 0.97 [0.95–1.00]) and Left ventricular diastolic dysfunction (Odds Ratio: 2.25 [1.02–4.95]) were associated with progression of left ventricular dysfunction as reflected by strain analysis.

Conclusion: In this large cohort of systemic sclerosis patients, decline of left ventricular function was detected by speckle tracking strain analysis, and increase of percentage of patients with diastolic dysfunction. At baseline, proximal muscle weakness, diffusing capacity of carbon monoxide, and left ventricular diastolic function may identify patients at higher risk for deterioration of cardiac function and in need of closer cardiac monitoring by means of annual repeated echocardiography.    Table 1. Echocardiographic parameters at baseline and follow-up; n= 235 Abbreviations: LEVF= Left Ventricular Ejection Fraction; GLS= Global Longitudinal Strain; LV= Left Ventricular; sPAP= systolic Pulmonary Arterial Pressure; PAH= Pulmonary Arterial Hypertension; TAPSE = Tricuspid Annular Plane Systolic Excursion; PE= pericardial effusion

Baseline Follow-up P value
LEVF%, mean (SD) 62 (7) 61 (8) 0.148
Global Longitudinal Strain (GLS) %, mean, (SD) -20.91 (2.01) -19.31 (2.47) < 0.001
Decline in GLS >= 15%, n (%) – 39 (17) –
Diastolic dysfunction, n (%) 73 (31) 108 (46) <0.001
LV diastolic dysfunction de novo, n (%) – 31 (13) –
LV diastolic dysfunction increase, n (%) 1 48 (20) –
sPAP mmHg, mean (SD) 26 (8) 28 (12) 0.060
New PAH at follow-up, n (%) – 13 (6) –
Persistent PAH, n (%) – 14 (6) –
TAPSE mm, mean (SD) 23 (4) 22 (4) 0.006
Pericardial Effusion (PE), n (%) 9 (4) 17 (7) < 0.001
New PE at follow-up, n (%) – 12 (5) –

           


Disclosure: S. Van Wijngaarden, None; S. Ben Said- Bouyeri, None; M. K. Ninaber, None; J. J. Bax, None; V. Delgado, None; J. K. de Vries-Bouwstra, None; N. Ajmone Marsan, None.

To cite this abstract in AMA style:

Van Wijngaarden S, Ben Said- Bouyeri S, Ninaber MK, Bax JJ, Delgado V, de Vries-Bouwstra JK, Ajmone Marsan N. Progression of Left Ventricular Myocardial Dysfunction in Systemic Sclerosis: Using Speckle Tracking Strain Echocardiography to Identify Patients at Risk [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/progression-of-left-ventricular-myocardial-dysfunction-in-systemic-sclerosis-using-speckle-tracking-strain-echocardiography-to-identify-patients-at-risk/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/progression-of-left-ventricular-myocardial-dysfunction-in-systemic-sclerosis-using-speckle-tracking-strain-echocardiography-to-identify-patients-at-risk/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology